Literature DB >> 12367615

The relative amount of cRNA coding for gamma2 subunits affects stimulation by benzodiazepines in GABA(A) receptors expressed in Xenopus oocytes.

A J Boileau1, R Baur, L M Sharkey, E Sigel, C Czajkowski.   

Abstract

Benzodiazepine (BZD) potentiation of GABA-activated Cl(-)-current (I(GABA)) in recombinant GABA(A) receptors requires the presence of the gamma subunit. When alpha1, beta2 and gamma2S cRNA are expressed in a 1:1:1 ratio in Xenopus oocytes, BZD potentiation of I(GABA) is submaximal, variable and diminishes over time. Potentiation by BZDs is increased, more reproducible and is stabilized over time by increasing the relative amount of cRNA coding for the gamma2S subunit. In addition, GABA EC(50) values for alpha1beta2gamma2 (1:1:1) receptors are intermediate to values measured for alpha1beta2 (1:1) and alpha1beta2gamma2 (1:1:10) receptors. We conclude that co-expression of equal ratios of alpha1, beta2 and gamma2 subunits in Xenopus oocytes produces a mixed population of alpha1beta2 and alpha1beta2gamma2 receptors. Therefore, for accurate measurements of BZD potentiation it is necessary to inject a higher ratio of gamma2 subunit cRNA relative to alpha1 and beta2 cRNA. This results in a purer population of alpha1beta2gamma2 receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12367615     DOI: 10.1016/s0028-3908(02)00036-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  48 in total

1.  Beta subunit phosphorylation selectively increases fast desensitization and prolongs deactivation of alpha1beta1gamma2L and alpha1beta3gamma2L GABA(A) receptor currents.

Authors:  David J Hinkle; Robert L Macdonald
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

2.  Positioning of the alpha-subunit isoforms confers a functional signature to gamma-aminobutyric acid type A receptors.

Authors:  Frédéric Minier; Erwin Sigel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

3.  Use of the covariance matrix in directly fitting kinetic parameters: application to GABAA receptors.

Authors:  James J Celentano; Alan G Hawkes
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

4.  The short splice variant of the gamma 2 subunit acts as an external modulator of GABA(A) receptor function.

Authors:  Andrew J Boileau; Robert A Pearce; Cynthia Czajkowski
Journal:  J Neurosci       Date:  2010-04-07       Impact factor: 6.167

5.  Optimized expression vector for ion channel studies in Xenopus oocytes and mammalian cells using alfalfa mosaic virus.

Authors:  Srinivasan P Venkatachalan; Jeremy D Bushman; José L Mercado; Feyza Sancar; Kelly R Christopherson; Andrew J Boileau
Journal:  Pflugers Arch       Date:  2006-12-05       Impact factor: 3.657

6.  Two etomidate sites in α1β2γ2 γ-aminobutyric acid type A receptors contribute equally and noncooperatively to modulation of channel gating.

Authors:  Grigori Guitchounts; Deirdre S Stewart; Stuart A Forman
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

Review 7.  Tandem couture: Cys-loop receptor concatamer insights and caveats.

Authors:  Spencer S Ericksen; Andrew J Boileau
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

8.  Unanticipated structural and functional properties of delta-subunit-containing GABAA receptors.

Authors:  Kuldeep H Kaur; Roland Baur; Erwin Sigel
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

9.  An intersubunit electrostatic interaction in the GABAA receptor facilitates its responses to benzodiazepines.

Authors:  Natasha C Pflanz; Anna W Daszkowski; Garrett L Cornelison; James R Trudell; S John Mihic
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

10.  Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation.

Authors:  Deirdre Stewart; Rooma Desai; Qi Cheng; Aiping Liu; Stuart A Forman
Journal:  Mol Pharmacol       Date:  2008-09-19       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.